New mathematical model shows promising results for prostate cancer treatment

byUniversity of PortsmouthGraphical abstract. Credit:Mathematical Biosciences(2022). DOI: 10.1016/j.mbs.2022.108940A new mathematical model which aims to optimize treatment for prost

Updated on: January 12,2024

New mathematical model shows promising results for prostate cancer treatment

byUniversity of PortsmouthGraphical abstract. Credit:Mathematical Biosciences(2022). DOI: 10.1016/j.mbs.2022.108940A new mathematical model which aims to optimize treatment for prost

Updated on:January 12,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on: January 04,2024

First randomized phase 3 clinical trial of neoadjuvant immunotherapy in patients with kidney cancer

by ECOG-ACRIN Cancer Research GroupCredit: Pixabay/CC0 Public DomainThe ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) will present data from PROSPER RCC (EA8143), the first randomized phase 3 trial of

Updated on:January 04,2024

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on: February 18,2024

Carcinogens found at Montana nuclear missile sites as reports of hundreds of cancers surface

by Tara CoppIn this image provided by the U.S. Air Force, Airman 1st Class Jackson Ligon, left, and Senior Airman Jonathan Marinaccio, 341st Missile Maintenance Squadron technicians connect a re-entry

Updated on:February 18,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on: March 30,2024

Scientists find core regulatory circuit controlling identity of aggressive leukemia

bySt. Jude Children's Research HospitalCo-corresponding author Brian J. Abraham, PhD, and co-author Kelsey Maher, PhD. Credit: St. Jude Children's Research HospitalA collaboration betwee

Updated on:March 30,2024

Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on: January 30,2024

Researchers find possible cause for chemoresistance in bowel cancer

by Martin-Luther-Universität Halle-WittenbergAnalysis of IGF2BP2 targets in tumor and metastatic CRC tissues. A, B Cumulative plot of gene expression (log2 fold change) in primary (A) and metastatic (

Updated on:January 30,2024

Study reveals potential target for precision colorectal cancer treatment

by Mallory Locklear,Yale UniversityFlowchart outlining the study. A: Metabolomics data collection and analysis; including targeted analysis of metabolites involved in ferroptosis pathways; B: Id

Updated on: February 18,2024

Study reveals potential target for precision colorectal cancer treatment

by Mallory Locklear,Yale UniversityFlowchart outlining the study. A: Metabolomics data collection and analysis; including targeted analysis of metabolites involved in ferroptosis pathways; B: Id

Updated on:February 18,2024

Targeting mutation slows breast cancer spread, study finds

Credit: Pixabay/CC0 Public DomainThe progression of certain types of breast cancers can be slowed by identifying a particular genetic mutation and then quickly adapting treatment, a first-of-its-kind

Updated on: January 23,2024

Targeting mutation slows breast cancer spread, study finds

Credit: Pixabay/CC0 Public DomainThe progression of certain types of breast cancers can be slowed by identifying a particular genetic mutation and then quickly adapting treatment, a first-of-its-kind

Updated on:January 23,2024

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Updated on: February 03,2024

Epigenetic age and lung cancer risk in a prospective cohort study

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainEpigenetic age, a robust marker of biological aging, has been associated with obesity, low-grade inflammation and metabolic diseases. However, fe

Updated on:February 03,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on: February 03,2024

A two-for-one approach to boost melanoma immunotherapy

by Sanford Burnham Prebys Medical Discovery InstituteCredit: Unsplash/CC0 Public DomainNew research from Sanford Burnham Prebys has helped explain how melanoma evades the immune system and may gu

Updated on:February 03,2024

Wildfire exposure decreases chances of survival for vulnerable cancer patients, study shows

by Rob Spahr,Emory UniversityCredit: Unsplash/CC0 Public DomainPeople exposed to a wildfire within a year after having lung cancer surgery have significantly lower chances of survival compared t

Updated on: January 16,2024

Wildfire exposure decreases chances of survival for vulnerable cancer patients, study shows

by Rob Spahr,Emory UniversityCredit: Unsplash/CC0 Public DomainPeople exposed to a wildfire within a year after having lung cancer surgery have significantly lower chances of survival compared t

Updated on:January 16,2024

Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on: January 16,2024

Software program that looks for the most effective drugs helps to personalize cancer treatments

byThe Spanish National Cancer Research CentreGraphical Abstract. Credit:Nucleic Acids Research(2023). DOI: 10.1093/nar/gkad412Precision medicine seeks to adapt treatments to the char

Updated on:January 16,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on: April 06,2024

Second primary malignancy risk increased after cutaneous B-cell lymphoma

by Elana GotkinePatients with primary cutaneous B-cell lymphomas (PCBCLs) have an increased risk for second primary malignancies (SPMs), according to a studypublishedonline March 19 in the

Updated on:April 06,2024